Aortic thrombosis (AT) is a primary or secondary change to systemic diseases (
WINTER & BUDKE, 2017) and causes ischemic neuromyopathy as a consequence of partial or total obstruction of blood flow to one or both pelvic limbs due to the presence of a thrombus (
GONÇALVES et al., 2008). The etiologies behind the formation of this thrombus in dogs are diverse and include neoplasm, protein loss nephropathy and/or enteropathy, hypothyroidism, diabetes mellitus, hyper or hypoadrenocorticism, as well as corticosteroid administration (
WINKLE et al., 1993; GONÇALVES et al., 2008;
LAKE-BAKAAR et al., 2012;
WINTER e BUBKE, 2017). However, CLL has not yet been included in the list of neoplasms that predispose dogs to this condition. In humans, the risk of venous thrombosis is recognized in patients with CLL (
WHITTLE et al., 2011) due to both hyperleukocytosis (
CUKIERMAN et al., 2002) and the presence of prothrombotic factors related to neoplasms (
CRESPO-SOLÍS, 2012). No reports of arterial thrombosis were reported in humans or other animal species secondary to CLL. Therefore, this report aimed to describe a case of aortic thrombosis secondary to chronic lymphocytic leukemia in a dog.